Messy Health Care Merger To End Up In Court
On Monday, U.S.-based health care giant Ventana announced that it would not raise its $2.13 per share offer for Vision, even after being outbid by rival health care company Cytyc. Instead, it would allow the merger plans, which Vision had already accepted, to lapse.
Cytyc had offered to buy Vision for $2.34 a share, or around $375 million....
To view the full article, register now.